ArticleVaccines2023

Immunogenicity and Safety of MF59-Adjuvanted Quadrivalent Influenza Vaccine Compared with a Nonadjuvanted, Quadrivalent Influenza Vaccine in Adults 50-64 Years of Age.

Airi Poder et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.